Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Long-Term Investments: 2023-2024

  • Zhengye Biotechnology Holding's Long-Term Investments rose 2.66% to $38.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $38.9 million, marking a year-over-year increase of 2.66%. This contributed to the annual value of $38.9 million for FY2024, which is 0.76% up from last year.
  • According to the latest figures from Q4 2024, Zhengye Biotechnology Holding's Long-Term Investments is $38.9 million, which was up 2.66% from $37.9 million recorded in Q4 2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Long-Term Investments registered a high of $38.9 million during Q4 2024, and its lowest value of $37.9 million during Q4 2023.
  • Its 2-year average for Long-Term Investments is $38.4 million, with a median of $38.4 million in 2023.
  • Data for Zhengye Biotechnology Holding's Long-Term Investments shows a peak YoY rose of 2.66% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Long-Term Investments (Quarterly) stood at $37.9 million in 2023, then rose by 2.66% to $38.9 million in 2024.